Company intelligence / Profile preview

CHRISTUS Stehlin Foundation for Cancer Research

Houston, Texas, United Statesstehlin.org ↗

Ownership: Private
Employees: ~21
Development stage: Other

Overview

The foundation has supported early-stage clinical research, including a completed Phase 1 trial (NCT00947739) with camptothecin derivative CZ-48 in solid tumors and lymphoma; further development status appears discontinued or pending and no late-stage or commercial products are reported.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologic
Industry: Academic Hospital/University/Research

Partnerships

New Mexico Cancer Care Alliance

Beyond the preview

Go deeper on CHRISTUS Stehlin Foundation for Cancer Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHRISTUS Stehlin Foundation for Cancer Research.